These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 28089722

  • 1. Perioperative Allogenic Blood Transfusion in Renal Cell Carcinoma: Risk Factors and Effect on Long-term Outcomes.
    Soria F, de Martino M, Leitner CV, Moschini M, Shariat SF, Klatte T.
    Clin Genitourin Cancer; 2017 Jun; 15(3):e421-e427. PubMed ID: 28089722
    [Abstract] [Full Text] [Related]

  • 2. The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC).
    Linder BJ, Thompson RH, Leibovich BC, Cheville JC, Lohse CM, Gastineau DA, Boorjian SA.
    BJU Int; 2014 Sep; 114(3):368-74. PubMed ID: 24471825
    [Abstract] [Full Text] [Related]

  • 3. Impact of Perioperative Allogenic Blood Transfusion on Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
    Rink M, Soave A, Dahlem R, Aziz A, Al-Sayed F, Peine S, Engel O, Kluth LA, Stenzl A, Burger M, Shariat SF, Fisch M, Fritsche HM, Gakis G.
    Clin Genitourin Cancer; 2016 Feb; 14(1):96-104. PubMed ID: 26506908
    [Abstract] [Full Text] [Related]

  • 4. Perioperative blood transfusion adversely affects prognosis after nephrectomy for renal cell carcinoma.
    Abu-Ghanem Y, Zilberman DE, Dotan Z, Kaver I, Ramon J.
    Urol Oncol; 2018 Jan; 36(1):12.e15-12.e20. PubMed ID: 28993059
    [Abstract] [Full Text] [Related]

  • 5. Impact of perioperative blood transfusion on oncologic outcomes in patients with nonmetastatic renal cell carcinoma treated with curative nephrectomy: A retrospective analysis of a large, single-institutional cohort.
    Seon DY, Kwak C, Kim HH, Ku JH, Kim HS.
    Investig Clin Urol; 2020 Mar; 61(2):136-145. PubMed ID: 32158964
    [Abstract] [Full Text] [Related]

  • 6. Intraoperative allogeneic blood transfusion is associated with adverse oncological outcomes in patients with surgically treated non-metastatic clear cell renal cell carcinoma.
    Kang HW, Seo SP, Kim WT, Yun SJ, Lee SC, Kim WJ, Hwang EC, Kang SH, Hong SH, Chung J, Kwon TG, Kim HH, Kwak C, Byun SS, Kim YJ, KORCC (KOrean Renal Cell Carcinoma) Group.
    Int J Clin Oncol; 2020 Aug; 25(8):1551-1561. PubMed ID: 32504136
    [Abstract] [Full Text] [Related]

  • 7. Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Rieken M, Schubert T, Xylinas E, Kluth L, Rouprêt M, Trinh QD, Lee RK, Al Hussein Al Awamlh B, Fajkovic H, Novara G, Margulis V, Lotan Y, Martinez-Salamanca JI, Matsumoto K, Seitz C, Remzi M, Karakiewicz PI, Scherr DS, Briganti A, Bachmann A, Shariat SF, UTUC Collaboration.
    Eur J Surg Oncol; 2014 Dec; 40(12):1693-9. PubMed ID: 24780094
    [Abstract] [Full Text] [Related]

  • 8. Perioperative blood transfusion affects oncologic outcomes after nephrectomy for renal cell carcinoma: A systematic review and meta-analysis.
    Iwata T, Kimura S, Foerster B, Abufaraj M, Karakiewicz PI, Preisser F, Nasu Y, Shariat SF.
    Urol Oncol; 2019 Apr; 37(4):273-281. PubMed ID: 30737159
    [Abstract] [Full Text] [Related]

  • 9. Impact of perioperative blood transfusion on prognosis after nephrectomy in patients with renal cell carcinoma: A meta-analysis and systematic review.
    Xu J, Bai J, Pan H, Zhou Z.
    Medicine (Baltimore); 2024 Apr 05; 103(14):e37646. PubMed ID: 38579099
    [Abstract] [Full Text] [Related]

  • 10. Intraoperative but not postoperative blood transfusion adversely affect cancer recurrence and survival following nephrectomy for renal cell carcinoma.
    Abu-Ghanem Y, Dotan Z, Zilberman DE, Kaver I, Ramon J.
    Sci Rep; 2019 Feb 04; 9(1):1160. PubMed ID: 30718860
    [Abstract] [Full Text] [Related]

  • 11. Effect of perioperative blood transfusion on mortality for major urologic malignancies.
    Soubra A, Zabell JR, Adejoro O, Konety BR.
    Clin Genitourin Cancer; 2015 Jun 04; 13(3):e173-81. PubMed ID: 25600760
    [Abstract] [Full Text] [Related]

  • 12. Perioperative Blood Transfusion Is a Predictor of Acute and Chronic Renal Function Deterioration after Partial and Radical Nephrectomy for Renal Cell Carcinoma.
    Mühlbauer J, de Gilde J, Mueller-Steinhardt M, Porubsky S, Walach M, Nuhn P, Klüter H, Wagener N, Kriegmair MC.
    Urol Int; 2020 Jun 04; 104(9-10):775-780. PubMed ID: 32721964
    [Abstract] [Full Text] [Related]

  • 13. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy.
    Linder BJ, Frank I, Cheville JC, Tollefson MK, Thompson RH, Tarrell RF, Thapa P, Boorjian SA.
    Eur Urol; 2013 May 04; 63(5):839-45. PubMed ID: 23332883
    [Abstract] [Full Text] [Related]

  • 14. Effect of blood transfusions on oncological outcomes of surgically treated localized renal cell carcinoma.
    Tsivian M, Abern MR, Tsivian E, Sze C, Jibara G, Rampersaud EN, Polascik TJ.
    Urol Oncol; 2018 Aug 04; 36(8):362.e1-362.e7. PubMed ID: 29793797
    [Abstract] [Full Text] [Related]

  • 15. Prognostic Significance of Preoperative Anemia in Patients Undergoing Surgery for Renal Cell Carcinoma: A Meta-analysis.
    Xia L, Hu G, Guzzo TJ.
    Anticancer Res; 2017 Jun 04; 37(6):3175-3181. PubMed ID: 28551661
    [Abstract] [Full Text] [Related]

  • 16. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S, May M, Shariat SF, Xylinas E, Stief C, Zigeuner R, Chromecki T, Burger M, Wieland WF, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Feciche B, Truss M, Gilfrich C, Pahernik S, Hohenfellner M, Zastrow S, Wirth MP, Novara G, Carini M, Minervini A, Simeone C, Antonelli A, Mirone V, Longo N, Simonato A, Carmignani G, Ficarra V, Members of the CORONA project and the SATURN project.
    Eur Urol; 2013 Sep 04; 64(3):472-7. PubMed ID: 22748912
    [Abstract] [Full Text] [Related]

  • 17. Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and Radical Cystectomy.
    Chalfin HJ, Liu JJ, Gandhi N, Feng Z, Johnson D, Netto GJ, Drake CG, Hahn NM, Schoenberg MP, Trock BJ, Scott AV, Frank SM, Bivalacqua TJ.
    Ann Surg Oncol; 2016 Aug 04; 23(8):2715-22. PubMed ID: 27012987
    [Abstract] [Full Text] [Related]

  • 18. Predictive factors for perioperative blood transfusions in partial nephrectomy for renal masses.
    Abu-Ghanem Y, Dotan Z, Kaver I, Ramon J.
    J Surg Oncol; 2015 Oct 04; 112(5):496-502. PubMed ID: 26437866
    [Abstract] [Full Text] [Related]

  • 19. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study.
    Vetterlein MW, Gild P, Kluth LA, Seisen T, Gierth M, Fritsche HM, Burger M, Protzel C, Hakenberg OW, von Landenberg N, Roghmann F, Noldus J, Nuhn P, Pycha A, Rink M, Chun FK, May M, Fisch M, Aziz A, PROMETRICS 2011 Study Group.
    BJU Int; 2018 Jan 04; 121(1):101-110. PubMed ID: 28905486
    [Abstract] [Full Text] [Related]

  • 20. ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma.
    Kaffenberger SD, Morgan TM, Stratton KL, Boachie AM, Barocas DA, Chang SS, Cookson MS, Herrell SD, Smith JA, Clark PE.
    BJU Int; 2012 Dec 04; 110(11 Pt B):E641-6. PubMed ID: 22958439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.